POTENTIALITY OF ANTICANCERUS AGENTS FROM MICROORGANISMS FOR TREATMENT OF CANCER

D K Acharya

B. N. Patel Institute of Paramedical and Science, India

Received Date: 2022-03-10 | Accepted Date: 2022-03-15 | Published Date: 2022-03-25

D K Acharya

B. N. Patel Institute of Paramedical and Science, India

Received date: 2022-03-10 | Accepted date: 2022-03-15 | Published date: 2022-03-25

Visit for more related articles at Reproductive Immunology: Open Access

Abstract

Cancer belongs to the main reason of morbidity and mortality in the world. Despite much progress in the diagnosis and treatment of cancer, it is one of the main reason of death worldwide. Cancerous cells are altered in host cells without the natural mechanism controlling their normal growth. The standard method of treatment often do not lead to the excepted effects. Therefore, it is important to find new more effective treatment. One of the most promising research direction is immunotherapy, including the use of specific types of microorganism amongst them are bacterial protein and peptides are promising group of bioactive compounds and potential anticancer drug. Some of them including anticancer antibiotics (Actinomycine-D, bleomycin, Doxorubicin, Mitomycin c) are already used in cancer treatment. This review shows the current literature data regarding the anticancer activity of protein and peptides originated from bacteria. It provides an overview of selected microorganism which are already in use or that are in experiment phase. Nevertheless the kind of treatment can supplement conventional anticancer therapy, giving cancer patient a chance and hope of recovery.

open access journals, open access scientific research publisher, open access publisher
Select your language of interest to view the total content in your interested language

Viewing options

Flyer image

Share This Article